As part of China Grand Enterprises Pharmaceuticals and Healthcare (CGE Healthcare),Xianle Pharma is a global leading manufacturer of steroid hormones with two cGMP manufacturing sites:Zhejiang Xianju Xianle & Jiangsu Grand Xianle,which have successfully passed NMPA,EDQM & WHO inspections.
Xianle Pharma mainly produces Betamethasone series,Dexamethasone series,Cyproterone Acetate series,Prednisolone series and Progesterone series,and provides CDMO services of various APIs and intermediates.
more >
Year of Establishment:
--
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
N;
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
N;
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Advantage Description: